Breaking News

Antheia Receives $40 million in Venture Debt Financing

Announces plans to construct a new pilot scale biomanufacturing facility.

Author Image

By: Charlie Sternberg

Associate Editor

Antheia, a synthetic biology company, has announced $40 million in venture debt financing from Oxford Finance LLC and Silicon Valley Bank, alongside plans to construct a new pilot scale biomanufacturing facility.   The financing will support Antheia’s expansion with a 14,700 square-foot pilot plant located next to Antheia’s headquarters in Menlo Park, CA. The new pilot plant will enable the company to significantly improve efficiency and support the scale up of its growing portfoli...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters